We are excited to let you know that Cambridge University Press will convert its leading journal, Primary Health Care Research & Development also EFPC official journal, to Open Access from January 2019. All articles submitted after October 1st 2018 will be published under the Creative Commons Attribution License (CC-BY), which permits use, distribution, reproduction and adaptation in any medium, provided the original work is properly cited. This means that all articles in the journal will be freely available to view, download and share, ensuring that anyone can benefit from and build upon the work.
To view our FAQs, please click here.
Why is Cambridge University Press converting Primary Health Care Research & Development to the Open Access model?
Cambridge University Press is committed to the principles of Open Research, of which Open Access publishing is an essential pillar. The Press and the journal’s Editors firmly believe that converting the journal to Open Access will ensure much greater visibility and impact of the high quality research that it publishes, strengthening its position as a highly influential publication in the field. We also understand that the Open Access model is preferred by funders in this discipline, with data indicating that authors and institutions are increasingly choosing to publish Open Access.
What will be the process for submitting articles from 1st October 2018?
Articles will be submitted through the same system as now and will undergo exactly the same rigorous peer review, with no expected change in acceptance or rejection rates. An Article Processing Charge (APC) will be payable by authors or their funder on acceptance of their primary research article. Certain article types will be published Open Access without charge to the authors: the instructions for contributors will be updated with more information shortly. Please note that submissions to the journal before 1st October 2018 will not be subject to an APC.
The types of papers that will not incur a charge to authors are:
Editorials; Alma Ata Special Issue Papers; Development Papers; Cochrane Review Summaries; up to four EFPC Position Statement Papers (per year).
We, the Editors of the Journal, look forward to working with you as we enter this new exciting phase of development of PHCR&D.
Sally Kendall and Rosamund Bryar